BMP4 inhibits PDGF-induced proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in pulmonary artery smooth muscle cells

被引:22
作者
Cai, Pengcheng [1 ,5 ]
Kovacs, Laszlo [1 ]
Dong, Sam [1 ]
Wu, Guangyu [1 ]
Su, Yunchao [1 ,2 ,3 ,4 ]
机构
[1] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, 1120 15th St, Augusta, GA 30912 USA
[2] Augusta Univ, Dept Med, Med Coll Georgia, Augusta, GA USA
[3] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Augusta, GA USA
[4] Charlie Norwood Vet Affairs Med Ctr, Res Serv, Augusta, GA USA
[5] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Clin Lab, Wuhan, Hubei, Peoples R China
关键词
pulmonary hypertension; lung; vascular smooth muscle cells; BONE MORPHOGENETIC PROTEIN; EPIDERMAL-GROWTH-FACTOR; GERMLINE MUTATIONS; BETA FAMILY; HYPERTENSION; RECEPTOR; ACTIVATION; KINASE; PHOSPHORYLATION; EXPRESSION;
D O I
10.1152/ajplung.00260.2016
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In the present study, we investigated the effect of bone morphogenetic protein 4 (BMP4) on PDGF-induced cell proliferation and collagen synthesis in pulmonary artery smooth muscle cells (PASMCs). Normal human PASMCs were incubated with and without PDGF-BB in the absence and presence of BMP4 for 0.5 to 24 h. The protein levels of collagen-I, p-Smad2/3, p-Smad1/5, and intracellular active TGF- 1, calpain activity, and cell proliferation were then measured. The results showed that BMP4 induced an increase in p-Smad1/5 but had no effect on the protein levels of collagen-I, p-Smad2/3, and intracellular active TGF-beta 1 and calpain activity in control PASMCs. Nevertheless, BMP4 attenuated increases in cell proliferation and protein levels of collagen-I, p-Smad2/3, and intracellular active TGF-beta 1 and calpain activity in PASMCs exposed to PDGF-BB. Moreover, BMP4 increased PKA activity and inhibition of PKA prevented the inhibitory effects of BMP4 on PDGF-BB-induced calpain activation in normal PASMCs. The PKA activator forskolin recapitulated the suppressive effect of BMP4 on PDGF-induced calpain activation. Furthermore, BMP4 prevented a PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in normal PASMCs. Finally, BMP4 did not attenuate PDGF-induced increases in cell proliferation, collagen-I protein levels, and calpain activation and did not induce PKA activation and did not prevent a PDGF-induced decrease in calpain-2 phosphorylation at serine-369 in PASMCs from idiopathic pulmonary arterial hypertension (PAH) patients. These data demonstrate that BMP4 inhibits PDGF-induced cell proliferation and collagen synthesis via PKA-mediated inhibition of calpain-2 in normal PASMCs. The inhibitory effects of BMP4 on PDGF-induced cell proliferation, collagen synthesis, and calpain-2 activation are impaired in PASMCs from PAH patients, which may contribute to pulmonary vascular remodeling in PAH.
引用
收藏
页码:1638 / 1648
页数:11
相关论文
共 35 条
  • [1] Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling
    Amanchy, Ramars
    Zhong, Jun
    Hong, Rosa
    Kim, James H.
    Gucek, Marjan
    Cole, Robert N.
    Molina, Henrik
    Pandey, Akhilesh
    [J]. MOLECULAR ONCOLOGY, 2009, 3 (5-6): : 439 - 450
  • [2] Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor
    Atkinson, C
    Stewart, S
    Upton, PD
    Machado, R
    Thomson, JR
    Trembath, RC
    Morrell, NW
    [J]. CIRCULATION, 2002, 105 (14) : 1672 - 1678
  • [3] Role of platelet-derived growth factor in vascular remodeling during pulmonary hypertension in the ovine fetus
    Balasubramaniam, V
    Le Cras, TD
    Ivy, DD
    Grover, TR
    Kinsella, JP
    Abman, SH
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2003, 284 (05) : L826 - L833
  • [4] Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors
    Chen, YG
    Massagué, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (06) : 3672 - 3677
  • [5] Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
    Deng, ZM
    Morse, JH
    Slager, SL
    Cuervo, N
    Moore, KJ
    Venetos, G
    Kalachikov, S
    Cayanis, E
    Fischer, SG
    Barst, RJ
    Hodge, SE
    Knowles, JA
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (03) : 737 - 744
  • [6] Bone morphogenetic protein signalling in heritable versus idiopathic pulmonary hypertension
    Dewachter, L.
    Adnot, S.
    Guignabert, C.
    Tu, L.
    Marcos, E.
    Fadel, E.
    Humbert, M.
    Dartevelle, P.
    Simonneau, G.
    Naeije, R.
    Eddahibi, S.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (05) : 1100 - 1110
  • [7] Bone morphogenetic protein 4 promotes pulmonary vascular remodeling in hypoxic pulmonary hypertension
    Frank, DB
    Abtahi, A
    Yamaguchi, DJ
    Manning, S
    Shyr, Y
    Pozzi, A
    Baldwin, HS
    Johnson, JE
    de Caestecker, MP
    [J]. CIRCULATION RESEARCH, 2005, 97 (05) : 496 - 504
  • [8] Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation
    Glading, A
    Bodnar, RJ
    Reynolds, IJ
    Shiraha, H
    Satish, L
    Potter, DA
    Blair, HC
    Wells, A
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (06) : 2499 - 2512
  • [9] The calpain system
    Goll, DE
    Thompson, VF
    Li, HQ
    Wei, W
    Cong, JY
    [J]. PHYSIOLOGICAL REVIEWS, 2003, 83 (03) : 731 - 801
  • [10] Proteins associated with type II bone morphogenetic protein receptor (BMPR-II) and identified by two-dimensional gel electrophoresis and mass spectrometry
    Hassel, S
    Eichner, A
    Yakymovych, M
    Hellman, U
    Knaus, P
    Souchelnytskyi, S
    [J]. PROTEOMICS, 2004, 4 (05) : 1346 - 1358